// App-Quantinova.ai

2606 : Clofarabine in the Frontline Treatment of Childhood Acute Lymphoblastic Leukemia. Results of the COALL 0809 Study Regarding Safety and Efficacy of Clofarabine in Combination with Asparaginase During Consolidation Therapy.

Researchers

Presenter

  • Gabriele Escherich

Principal Investigators

  • Martin Zimmermann

  • Martin A. Horstmann

Medical Centers

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

  • Pediatric Hem., Hamburg Univ. Med. Ctr., Hamburg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Nephrotoxicity

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Methotrexate

  • Asparaginase

  • Clofarabine

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved